IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 95

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: A Study On the Management of Kidney Disease Associated with COVID-19 in a Tertiary Care Hospital
Authors Name: Thahaniya Salim KP , Sneha PV , Muhammed Fazil AC , Afrah CM , Soumya MK
Download E-Certificate: Download
Author Reg. ID:
IJNRD_197306
Published Paper Id: IJNRD2305877
Published In: Volume 8 Issue 5, May-2023
DOI:
Abstract: Aim: To study the management of Kidney-disease associated with COVID-19 in patients admitted to the department of nephrology in a tertiary care hospital. Methodology: A prospective observational study was conducted over 6 months among 102 patients. Materials and Methods: All the data are collected, entered, and documented into the Excel sheet based on the protocol. The collected data was Statistically Analysed using Microsoft Excel and SPSS software. Results: Out of 102 population diagnosed with kidney disease with COVID-19, the majority of the patients were male, the study contains 67% of male patients. Disease conditions were commonly seen among the age group of 51-70 years. Major co-morbidities associated were hypertension. Patients suffered most commonly from fever. In our study, most of the Kidney patients had the mild category of COVID-19 which is Category C of COVID-19. We also did a study comparing oxygen saturation level with that of respiratory rate in patients with COVID 19 and mortality rate was found more among patients with decreased oxygen level and increased respiratory rate. Among the admitted patients, the majority of them belonged to stage 5 of CKD. Stage determination of CKD was done on the basis of calculated GFR value. The majority of patients fall under the GFR category of less than 15 ml/min. As patients were suffering from kidney disease dialysis was done, most commonly with the frequency of 3 times a week with a duration of 4 hours. Different categories of drugs like Vitamin supplements, Antibiotics, Antivirals, Corticosteroids, Erythropoiesis stimulating agents, Iron supplements, Anticoagulants, Diuretics, Inotropes, and Monoclonal antibodies were prescribed in our study, out of which Vitamin supplements were given the most among the 102 hospitalized patients. Among Vitamin supplements, Vitamin B Complex with Vitamin B 12, Penicillin and beta-lactamase inhibitors Piperacillin and Tazobactam among antibiotics, Ritonavir among antivirals, Regular heparin among anticoagulants, Iron sucrose among Iron supplements, Methylprednisolone among Corticosteroids, Torsemide among diuretics, Erythropoietin among Erythropoiesis Stimulating Agents, Adrenaline among Inotropes, Casirivimab + Imdevimab among Monoclonal Antibody Supportive care like Oxygen support, ICU, mechanical ventilation, and NIV was given. Most of the patients required oxygen support. During hospitalization, 27 out of 102 patients were dead. Conclusion: The emergence of COVID-19 required the emergency attention of the healthcare system as the etiology and pathophysiology of the disease were unknown at the beginning. All the initial steps of therapy and supportive care given in our study evaluated that it reduced hospitalization and mortality rate among the patients.
Keywords: Kidney disease associated with COVID-19 Management, Age wise distribution, GFR less than 15 ml/min, Kidney disease stage, Dialysis frequency, Oxygen saturation, respiratory rate prediction in COVID-19, Supportive cares given, Mortality rate.
Cite Article: "A Study On the Management of Kidney Disease Associated with COVID-19 in a Tertiary Care Hospital", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 5, page no.i682-i701, May-2023, Available :http://www.ijnrd.org/papers/IJNRD2305877.pdf
Downloads: 000118763
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2305877
Registration ID: 197306
Published In: Volume 8 Issue 5, May-2023
DOI (Digital Object Identifier):
Page No: i682-i701
Country: Kannur, Kerala, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2305877
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2305877
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD